![]()
19
| 1 | 2006
Klinisk Biokemi i Norden
a homogeneous immunometric assay for
interference. Clin Chem Lab Med 2004; 42
(2); 208-14.
10. Bjerner J et al. Immunometric assay inter-
ference: incidence and prevention. Clin
Chem 2002; 48 (4); 613-21.
11. Ismail AA et al. Wrong biochemistry
results: two case reports and observational
study in 5310 patients on potentially mis-
leading thyroid-stimulating hormone and
gonadotropin immunoassay results. Clin
Chem 2002; 48 (11); 2023-9.
12. Boscato LM, Stuart MC. Incidence and spe-
cificity of interference in two-site immu-
noassays. Clin Chem 1986; 32 ; 1491-5.
13. HAMA Survey Group. Survey of met-
hods for measuring human anti-mouse
antibodies. Clin Chim Acta 1993; 215 (2);
153-63.
14. Sim RB, Tsiftsoglou SA. Proteases of the
complement system. Biochem Soc Trans
2004; 32 (Pt 1); 21-7.
15. Børmer OP. Interference of complement
with the binding of carcinoembryonic
antigen to solid-phase monoclonal anti-
bodies. J Immunol Methods 1989; 121 ;
85-93.
16. Larsson A et al. Chicken antibodies: a
tool to avoid interference by complement
activation in ELISA. J Immunol Methods
1992; 156 (1); 79-83.
17. Frengen J et al. Demonstration and mini-
mization of serum interference in flow
cytometric two-site immunoassays. Clin
Chem 1994; 40 ; 420-5.
18. Lenz H, Mossner E, Stock W, Roder A,
Haug H, McCarthy RC. Reagent and met-
hod for determination of a polyvalent
substance using an immunoaggregate. US
Patent 164054. Issued 4-3-1990. Assignees
Boehringer Mannheim GmbH, Mannheim
DE.
19. Kuroki M et al. Reducing interference
from heterophilic antibodies in a two-
site immunoassay for carcinoembryonic
antigen (CEA) by using a human/mouse
chimeric antibody to CEA as the tracer. J
Immunol Methods 1995; 180 ; 81-91.
20. Warren DJ et al. Use of an
in vivo
bio-
tinylated single-chain antibody as cap-
ture reagent in an immunometric assay to
decrease the incidence of interference from
heterophilic antibodies. Clin Chem 2005;
51 (5); 830-8.
21. Ismail AA. A radical approach is needed
to eliminate interference from endogenous
antibodies in immunoassays. Clin Chem
2005; 51 (1); 25-6.
22. Primus FJ et al. ”Sandwich”-type immu-
noassay of carcinoembryonic antigen in
patients receiving murine monoclonal
antibodies for diagnosis and therapy. Clin
Chem 1988; 34 (2); 261-4.
23. Turpeinen U et al. Interference by human
anti-mouse antibodies in CA 125 assay
after immunoscintigraphy: anti-idiotypic
antibodies not neutralized by mouse IgG
but removed by chromatography. Clin
Chem 1990; 36 (7); 1333-8.
24. Rotmensch S, Cole LA. False diagnosis
and needless therapy of presumed malig-
nant disease in women with false-positive
human chorionic gonadotropin concentra-
tions. Lancet 2000; 355 (9205); 712-5.
25. Cole LA, Butler S. Detection of hCG in
trophoblastic disease. The USA hCG refe-
rence service experience. J Reprod Med
2002; 47 (6); 433-44.
26. Preissner CM et al. Prevalence of heterop-
hilic antibody interference in eight auto-
mated tumor marker immunoassays. Clin
Chem 2005; 51 (1); 208-10.
